RevBio Receives Grant to Develop TETRANITE for Spine Fractures
RevBio receives a $2.2 million phase II NIH grant to further develop the minimally invasive use of TETRANITE to treat...
RevBio receives a $2.2 million phase II NIH grant to further develop the minimally invasive use of TETRANITE to treat...
Dymicron shares how its Triadyme-C is engineered to reduce wear debris and mimic the natural kinematics and motion of a...
Introduction of the pre-op planning and modeling system completes the CORIOGRAPH Services portfolio, which includes solutions for knee and hip...
Bioretec's RemeOs screw is the first and only osteopromotive absorbable metal implant for orthopedic use in the U.S. ...
MNVC will feature dozens of orthopedic companies and provide attendees with a glimpse of the unmet needs that startups are...
Five things we're watching as the orthopedic market's competitive landscape evolves and we move into the second half of 2025....
The iTaperloc Complete and iG7 Hip System with Iodine Technology inhibits bacterial adhesion and prevents biofilm formation on the implant...
This new funding will fuel Spineart’s next phase of profitable growth, enabling the company to advance its innovation pipeline and...
This strategic move provides Poly Medicure with an entry point into the large global orthopedics market, particularly in the trauma...
The partnership expands SMAIO’s business in the U.S. and drives adoption of its new open platform for customized implant solutions....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.